Condition: Hospital Acquired Pneumonia (HAP) · Cardiovascular and Respiratory Disease · Sponsor: Nantes University Hospital
The HOMI-LUNG - HAP study is part of the HOMI-LUNG project, funded by the Horizon Europe program. The "HOMI-LUNG" project is an international, interdisciplinary project that aims to better understand the causal links between respiratory tract infections (i.e. pneumonia) and the progression of cardiovascular disease. More specifically, the project aims to quantify the burden of cardiovascular disease after pneumonia and assess patients; acceptability of long-term health alterations, as well as to define pneumonia endotypes with distinct pathobiological mechanisms associated with exacerbation of cardiovascular disease.
This description comes directly from the study's public registry record.
Antoine ROQUILLY · +33253482840 · Antoine.roquilly@univ-nantes.fr
Always discuss trial participation with your own doctor first.
| Angers University Hospital | Angers, France | Not Yet Recruiting |
| Nantes University Hospital | Nantes, France | Recruiting |
| Rennes University Hospital | Rennes, France | Not Yet Recruiting |
| Rouen University Hospital | Rouen, France | Not Yet Recruiting |
| Toulouse University Hospital | Toulouse, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06602934